[Federal Register Volume 81, Number 213 (Thursday, November 3, 2016)]
[Notices]
[Pages 76589-76590]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26570]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

    In accordance with section 10(a) (2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), National Center for Emerging and Zoonotic Infectious 
Diseases (NCEZID) announces a meeting of the aforementioned committee:
Times and Dates:
    9:00 a.m.-5:00 p.m., EST, December 1, 2016
    9:00 a.m.-12:00 p.m., EST, December 2, 2016
    Place: Centers for Disease Control and Prevention, Global 
Communications Center, Building 19, Auditorium B, 1600 Clifton Road 
NE., Atlanta, Georgia, 30329; Call-in number: 866-707-0452; Passcode: 
78829617.
    Status: Open to the public, in-person capacity is limited by the 
space available and 100 lines on the call-in number. Time will be 
available for public comment. The public is welcome to submit written 
comments in advance of the meeting. Comments should be submitted in 
writing by email to the contact person listed below. The deadline for 
receipt of written public comments is November 18, 2016. All requests 
must contain the name, address, and organizational affiliation of the 
speaker, as well as the topic being addressed. Written comments should 
not exceed one single-spaced typed page in length and delivered in 3 
minutes or less. Please note that the public comment period may end 
before the time indicated, following the last call for comments. 
Members of the public who wish to provide public comments should plan 
to attend the public comment session in-person at the start time 
listed. Written comments received in advance of the meeting will be 
included in the official record of the meeting.
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion, the 
Director, National Center for Emerging and Zoonotic Infectious Diseases 
(NCEZID), the Director, CDC, the Secretary, Health and Human Services 
regarding (1) the practice of healthcare infection prevention and 
control; (2) strategies for surveillance, prevention, and control of 
infections, antimicrobial resistance, and related events in settings 
where healthcare is provided; and (3) periodic updating of CDC 
guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters for Discussion: The agenda will include updates on CDC's 
activities for prevention of healthcare associated infections (HAIs), 
updates on antimicrobial stewardship, an update on infection prevention 
in long term care facilities, an update on Draft Infection Control 
Guidelines, and an update from the workgroup for considerations on 
endoscope reprocessing.
    Agenda items are subject to change as priorities dictate.
    Contact person for More Information: Erin Stone, M.S., HICPAC, 
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton 
Road NE., Mailstop A-07, Atlanta, Georgia 30329. Telephone (404) 639-
4045. Email: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 76590]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-26570 Filed 11-2-16; 8:45 am]
 BILLING CODE 4163-18-P